REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 247 participants.

Also called NCT01747174

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 247 participants (enrolled count) (from the registry)
Sponsor
University Hospitals, Leicester (from the registry)
Registry
  • NCT NCT01747174
  • EudraCT 2010-023211-34
Other papers using this trial's data
  • Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial European heart journal, 2016-06-21 DOI, PubMed 27147610, PMC4917746 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01747174. Randomized; single masking; primary purpose prevention. Start 2011-10 (registry gives no type); primary completion 2014-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction
Acronym
REFLO-STEMI
Condition
ST-elevation Myocardial Infarction (STEMI)
Intervention (Drug)
IC Adenosine
Intervention (Drug)
IC Sodium nitroprusside (SNP)
Intervention (Procedure)
Standard PCI (percutaneous coronary intervention)
Lead sponsor
University Hospitals, Leicester (class: other)

Record details

Record id
cardio:ct-nct01747174
Content hash
a1420170c9d776b29e7583b90d0b3189159bac7f7e93373bd93f45352d61465b